Open Access Case Report

Severely Elevated Fecal Calprotectin in A Pediatric Patient with Persistent Giardiasis

Melissa Shapiro1, Neha Shah2 and Sona Sehgal1*

1Division of Gastroenterology and Hepatology, Nutrition Children’s National Hospital, USA

2Johns Hopkins Bloomberg School of Public Health, USA

Corresponding Author

Received Date: December 15, 2020;  Published Date: January 28, 2021

Introduction

Giardia, a protozoan pathogen, is a leading cause of acute gastroenteritis worldwide with higher prevalence in developing countries. It is a treatable diagnosis that should be considered in any patient presenting with clinical symptoms of abdominal pain, bloating, and diarrhea. It is diagnosed with stool microcopy, antigen testing, or immunologic assay. There are few studies on whether Giardia should be considered in the setting of elevated fecal calprotectin (FC), a stool biomarker of intestinal inflammation. We present the case of a patient with markedly elevated FC in the setting of persistent, severe giardiasis.

Keywords: Giardia lamblia; Giardiasis; Fecal calprotectin

Abbreviations: FC: Fecal Calprotectin

Citation
Signup for Newsletter
Scroll to Top